Description: Presented at May 2002 Spring Meeting. Discusses the proposed new valuation table and how it affects future product development and design.

Description: This session discussed about expected trends in medical care costs, changes in Medicare reimbursement practices and their short- and long-term effects, the emerging responsibility for providing long-term care, rise of managed health care, new and old participants, selection issues, multiple options, and small group market.

Description: This discussion on long-term care [LTC] highlights secondary drivers in LTC experience in both insured and general populations. Practical applications of this new information for pricing, reserving and marketing is discussed. From the Record of the Society of Actuaries, Volume 28, No. 2, Session 42pd.

Description: Panel dicussion on the need for information to keep a block of long-term care insurance profitable: what the business risks are, what is being done to mitigate them, what kind of reports are needed, and how these differ from reporting on other types of health insurance.

Description: Discusses the need for a new life insurance valuation mortality table to replace the 1941 CSO, the authorization by the NAIC to form a committee to construct such a table, and the preliminary table developed.

Description: While this session was billed as C-2 risk, discussion focused almost entirely on HIV and AIDS, including the history, nature, spreading and mortality of the disease, and its impact on life and health insurance underwriting, pricing, and reserves. From the 1987 Record of Society of Actuaries, Vol. 13, No. 3.

Description: Discussion of the following underwriting topics: A. In view of the low rates of mortality currently experienced on standard lives, is the standard classification too narrow? B. Do substandard extra premiums at the lower ratings make fair provision for the additional expenses incurred on substandard policies? C. What problems are encountered in issuing life insurance on persons residing outside the continental United States and Canada? D. What changes have been made recently in non-medical selection and why? E. How could greater use be made of mortality or morbidity studies conducted by hospitals, clinics, government agencies, universities and others outside of the life insurance business?